1,240
Views
34
CrossRef citations to date
0
Altmetric
Research Article

Anti-arthritic effects of clematichinenoside (AR-6) on PI3K/Akt signaling pathway and TNF-α associated with collagen-induced arthritis

, , , , , , & show all
Pages 13-22 | Received 08 Jan 2012, Accepted 01 May 2012, Published online: 21 Sep 2012

References

  • Arntz OJ, Geurts J, Veenbergen S, Bennink MB, van den Brand BT, Abdollahi-Roodsaz S, van den Berg WB, van de Loo FA. (2010). A crucial role for tumor necrosis factor receptor 1 in synovial lining cells and the reticuloendothelial system in mediating experimental arthritis. Arthritis Res Ther, 12, R61.
  • Bingham CO 3rd. (2002). The pathogenesis of rheumatoid arthritis: Pivotal cytokines involved in bone degradation and inflammation. J Rheumatol Suppl, 65, 3–9.
  • Capria A, De Nardo D, Baffetti FR, Barbini U, Violo A, Tondo T, Fontana L. (2010). Long-term anti-TNF-α treatments reverse the endothelial dysfunction in rheumatoid arthritis: The biological coherence between synovial and endothelial inflammation. Int J Immunopathol Pharmacol, 23, 255–262.
  • Chang F, Lee JT, Navolanic PM, Steelman LS, Shelton JG, Blalock WL, Franklin RA, McCubrey JA. (2003). Involvement of PI3K/Akt pathway in cell cycle progression, apoptosis, and neoplastic transformation: a target for cancer chemotherapy. Leukemia, 17, 590–603.
  • Choy EH, Panayi GS. (2001). Cytokine pathways and joint inflammation in rheumatoid arthritis. N Engl J Med, 344, 907–916.
  • Downward J. (2004). PI 3-kinase, Akt and cell survival. Semin Cell Dev Biol, 15, 177–182.
  • Fingar DC, Blenis J. (2004). Target of rapamycin (TOR): An integrator of nutrient and growth factor signals and coordinator of cell growth and cell cycle progression. Oncogene, 23, 3151–3171.
  • Fishman P, Bar-Yehuda S, Madi L, Rath-Wolfson L, Ochaion A, Cohen S, Baharav E. (2006). The PI3K-NF-κB signal transduction pathway is involved in mediating the anti-inflammatory effect of IB-MECA in adjuvant-induced arthritis. Arthritis Res Ther, 8, R33.
  • Fishman P, Madi L, Bar-Yehuda S, Barer F, Del Valle L, Khalili K. (2002). Evidence for involvement of Wnt signaling pathway in IB-MECA mediated suppression of melanoma cells. Oncogene, 21, 4060–4064.
  • Goldring SR. (2003). Pathogenesis of bone and cartilage destruction in rheumatoid arthritis. Rheumatology (Oxford), 42, 11–16.
  • Gupta V, Wagner BJ. (2009). Search for a functional glucocorticoid receptor in the mammalian lens. Exp Eye Res, 88, 248–256.
  • Hashiramoto A, Sakai C, Yoshida K, Tsumiyama K, Miura Y, Shiozawa K, Nose M, Komai K, Shiozawa S. (2007). Angiopoietin 1 directly induces destruction of the rheumatoid joint by cooperative, but independent, signaling via ERK/MAPK and phosphatidylinositol 3-kinase/Akt. Arthritis Rheum, 56, 2170–2179.
  • Herlaar E, Brown Z. (1999). p38 MAPK signalling cascades in inflammatory disease. Mol Med Today, 5, 439–447.
  • Kim JE, Son JE, Jung SK, Kang NJ, Lee CY, Lee KW, Lee HJ. (2010). Cocoa polyphenols suppress TNF-α-induced vascular endothelial growth factor expression by inhibiting phosphoinositide 3-kinase (PI3K) and mitogen-activated protein kinase kinase-1 (MEK1) activities in mouse epidermal cells. Br J Nutr, 104, 957–964.
  • Li T, Zuo X, Zhou Y, Wang Y, Zhuang H, Zhang L, Zhang H, Xiao X. (2010). The vagus nerve and nicotinic receptors involve inhibition of HMGB1 release and early pro-inflammatory cytokines function in collagen-induced arthritis. J Clin Immunol, 30, 213–220.
  • Ma X, Xie L, Liu L, Tang Q, Wan Z, Li Y. (2009). Simultaneous quantification of seven main triterpenoid saponins in Radix et Rhizoma Clematidis by LC–ELSD. Chromatographia, 69, 437-43.
  • Matsuno H, Yudoh K, Katayama R, Nakazawa F, Uzuki M, Sawai T, Yonezawa T, Saeki Y, Panayi GS, Pitzalis C, Kimura T. (2002). The role of TNF-α in the pathogenesis of inflammation and joint destruction in rheumatoid arthritis (RA): A study using a human RA/SCID mouse chimera. Rheumatology (Oxford), 41, 329–337.
  • Miossec P. (2004). An update on the cytokine network in rheumatoid arthritis. Curr Opin Rheumatol, 16, 218–222.
  • Montalban AG, Boman E, Chang CD, Ceide SC, Dahl R, Dalesandro D, Delaet NG, Erb E, Ernst J, Gibbs A, Kahl J, Kessler L, Lundström J, Miller S, Nakanishi H, Roberts E, Saiah E, Sullivan R, Wang Z, Larson CJ. (2010). KR-003048, a potent, orally active inhibitor of p38 mitogen-activated protein kinase. Eur J Pharmacol, 632, 93–102.
  • O’Dell JR. (2004). Therapeutic strategies for rheumatoid arthritis. N Engl J Med, 350, 2591–2602.
  • Ochaion A, Bar-Yehuda S, Cohen S, Amital H, Jacobson KA, Joshi BV, Gao ZG, Barer F, Patoka R, Del Valle L, Perez-Liz G, Fishman P. (2008). The A3 adenosine receptor agonist CF502 inhibits the PI3K, PKB/Akt and NF-κB signaling pathway in synoviocytes from rheumatoid arthritis patients and in adjuvant-induced arthritis rats. Biochem Pharmacol, 76, 482–494.
  • Peng C, Perera PK, Li YM, Fang WR, Liu LF, Li FW. (2011). Anti-inflammatory effects of Clematis chinensis Osbeck extract(AR-6) may be associated with NF-κB, TNF-α, and COX-2 in collagen-induced arthritis in rat. Rheumatol Int. [Epub ahead of print].
  • Perera PK, Peng C, Xue L, Li Y, Han C. (2011). Ex vivo and in vivo effect of Chinese herbal pill Yi Shen Juan Bi (YJB) on experimental arthritis. J Ethnopharmacol, 134, 171–175.
  • Setty AR, Sigal LH. (2005). Herbal medications commonly used in the practice of rheumatology: Mechanisms of action, efficacy, and side effects. Semin Arthritis Rheum, 34, 773–784.
  • Sun SX, Li YM, Fang WR, Cheng P, Liu L, Li F. (2010). Effect and mechanism of AR-6 in experimental rheumatoid arthritis. Clin Exp Med, 10, 113–121.
  • Tong XM, Wang JC, Shen Y, Xie JJ, Zhang JY, Jin J. (2011). Inhibition of inflammatory mediators and related signaling pathways by macrophage-stimulating protein in rheumatoid arthritis synovial fibroblasts. Inflamm Res, 60, 823–829.
  • Williams-Skipp C, Raman T, Valuck RJ, Watkins H, Palmer BE, Scheinman RI. (2009). Unmasking of a protective tumor necrosis factor receptor I-mediated signal in the collagen-induced arthritis model. Arthritis Rheum, 60, 408–418.
  • Wu T, Mohan C. (2009). The AKT axis as a therapeutic target in autoimmune diseases. Endocr Metab Immune Disord Drug Targets, 9, 145–150.
  • Zwerina J, Hayer S, Redlich K, Bobacz K, Kollias G, Smolen JS, Schett G. (2006). Activation of p38 MAPK is a key step in tumor necrosis factor-mediated inflammatory bone destruction. Arthritis Rheum, 54, 463–472.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.